PL1704148T3 - Nowe skondensowane pirolokarbazole - Google Patents

Nowe skondensowane pirolokarbazole

Info

Publication number: PL1704148T3
Authority: PL; Poland
Prior art keywords: novel fused; fused pyrrolocarbazoles; pyrrolocarbazoles; novel; fused
Prior art date: 2003-12-23

Application number

PL04815262T

Other languages

English (en)

Inventor

Nadine C Becknell

James L Diebold

Diane E Gingrich

Robert L Hudkins

Dandu R Reddy

Ming Tao

Theodore L Underiner

Allison L Zulli

Original Assignee

Cephalon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-23

Filing date

2004-12-23

Publication date

2011-07-29

2004-12-23 Application filed by Cephalon Inc filed Critical Cephalon Inc

2011-07-29 Publication of PL1704148T3 publication Critical patent/PL1704148T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Virology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
AIDS & HIV (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Psychiatry (AREA)
Endocrinology (AREA)

PL04815262T 2003-12-23 2004-12-23 Nowe skondensowane pirolokarbazole PL1704148T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US53218203P	2003-12-23	2003-12-23
US11/017,947 US7169802B2 (en)	2003-12-23	2004-12-22	Fused pyrrolocarbazoles
EP04815262A EP1704148B1 (en)	2003-12-23	2004-12-23	Novel fused pyrrolocarbazoles
PCT/US2004/043160 WO2005063763A1 (en)	2003-12-23	2004-12-23	Novel fused pyrrolocarbazoles

Publications (1)

Publication Number	Publication Date
PL1704148T3 true PL1704148T3 (pl)	2011-07-29

Family

ID=34703676

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04815262T PL1704148T3 (pl)	2003-12-23	2004-12-23	Nowe skondensowane pirolokarbazole

Country Status (29)

Country	Link
US (4)	US7169802B2 (pl)
EP (1)	EP1704148B1 (pl)
JP (1)	JP5006046B2 (pl)
KR (2)	KR20120066057A (pl)
CN (1)	CN1918162B (pl)
AR (1)	AR047168A1 (pl)
AT (1)	ATE500256T1 (pl)
AU (1)	AU2004309394B2 (pl)
BR (1)	BRPI0418113B8 (pl)
CA (1)	CA2549627C (pl)
CR (1)	CR8519A (pl)
CY (1)	CY1111524T1 (pl)
DE (1)	DE602004031672D1 (pl)
DK (1)	DK1704148T3 (pl)
EA (1)	EA012295B1 (pl)
HR (1)	HRP20110373T1 (pl)
IL (1)	IL176384A (pl)
IS (1)	IS8519A (pl)
MA (1)	MA28298A1 (pl)
MY (2)	MY143373A (pl)
NO (2)	NO336893B1 (pl)
NZ (1)	NZ548099A (pl)
PL (1)	PL1704148T3 (pl)
PT (1)	PT1704148E (pl)
RS (1)	RS51886B (pl)
SG (1)	SG149045A1 (pl)
SI (1)	SI1704148T1 (pl)
TW (1)	TWI355385B (pl)
WO (1)	WO2005063763A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060276497A1 (en) *	2000-05-09	2006-12-07	Cephalon, Inc.	Novel multicyclic compounds and the use thereof
US7241779B2 (en) *	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles
SE0401790D0 (sv) *	2004-07-07	2004-07-07	Forskarpatent I Syd Ab	Tamoxifen response in pre- and postmenopausal breast cancer patients
EP2064178A4 (en) *	2006-09-08	2011-10-05	Merck Canada Inc	PRODRUGS OF INHIBITORS OF CATHEPSIN S
US20080125377A1 (en) *	2006-11-28	2008-05-29	Bartels Stephen P	Delivery system for antiangiogenic and antiinflammatory pharmaceuticals and method of use
WO2008151323A1 (en) *	2007-06-08	2008-12-11	University Of Massachusetts	Mixed lineage kinases and metabolic disorders
TWI580694B (zh)	2007-11-30	2017-05-01	建南德克公司	抗-ｖｅｇｆ抗體
UA107652C2 (en)	2008-10-06	2015-02-10	Incuron Llc	Carbazole compounds and therapeutic uses of the compounds
CA2741089A1 (en)	2008-10-22	2010-04-29	Genentech, Inc.	Modulation of axon degeneration
JP2012509282A (ja) *	2008-11-19	2012-04-19	セファロン、インク．	インダゾロ［５，４−ａ］ピロロ［３，４−ｃ］カルバゾール化合物の新しい形態
EP2192121A1 (en)	2008-11-27	2010-06-02	Cephalon France	Regioselective reduction of fused pyrrolocarbazoles-5,7-diones
KR101714799B1 (ko) *	2008-12-30	2017-03-09	아르퀼 인코포레이티드	치환된 5,6-디히드로-6-페닐벤조［ｆ］이소퀴놀린-2-아민 화합물
AU2009335016A1 (en) *	2008-12-30	2011-08-18	Arqule, Inc.	Substituted pyrazolo [3, 4-b] pyridine compounds
EP2490698A4 (en) *	2009-10-22	2013-09-25	Hoffmann La Roche	MODULATION OF AXONES DEGENERATION
US20110189174A1 (en)	2010-02-01	2011-08-04	Afshin Shafiee	Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
PH12012502250A1 (en)	2010-05-18	2013-02-04	Cephalon Inc	Method for purifying a fused pyrrolocarbazole derivative
CN103664797A (zh) *	2012-09-25	2014-03-26	杨子娇	一类治疗房角狭窄的化合物及其用途
CN104370880A (zh) *	2013-01-24	2015-02-25	韩冰	一类蛋白酶抑制剂及其制备方法和用途
CN104981697B (zh)	2013-02-11	2017-08-04	英丘伦有限责任公司	促染色质转录复合物(fact)在癌症中的用途
JP2016536350A (ja) *	2013-09-26	2016-11-24	シーエイチディーアイファウンデーション，インコーポレーテッド	キヌレニン−３−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法
US10434086B2 (en)	2014-04-06	2019-10-08	Incuron, Inc.	Combination therapies with curaxins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ245203A (en)	1991-11-29	1997-07-27	Banyu Pharma Co Ltd	5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5705511A (en)	1994-10-14	1998-01-06	Cephalon, Inc.	Fused pyrrolocarbazoles
US5591855A (en) *	1994-10-14	1997-01-07	Cephalon, Inc.	Fused pyrrolocarbazoles
US5475110A (en) *	1994-10-14	1995-12-12	Cephalon, Inc.	Fused Pyrrolocarbazoles
US5594009A (en) *	1994-10-14	1997-01-14	Cephalon, Inc.	Fused pyrrolocarbazoles
US5616724A (en) *	1996-02-21	1997-04-01	Cephalon, Inc.	Fused pyrrolo[2,3-c]carbazole-6-ones
AU710669B2 (en)	1996-08-22	1999-09-23	Bristol-Myers Squibb Company	Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
US6841567B1 (en) *	1999-02-12	2005-01-11	Cephalon, Inc.	Cyclic substituted fused pyrrolocarbazoles and isoindolones
US6399780B1 (en)	1999-08-20	2002-06-04	Cephalon, Inc.	Isomeric fused pyrrolocarbazoles and isoindolones
US6630500B2 (en) *	2000-08-25	2003-10-07	Cephalon, Inc.	Selected fused pyrrolocarbazoles
ES2220811T3 (es)	2000-09-29	2004-12-16	Eli Lilly And Company	Procedimiento y compuestos para el tratamiento de enfermedades proliferativas.
US6610727B2 (en)	2000-10-06	2003-08-26	Bristol-Myers Squibb Company	Anhydro sugar derivatives of indolocarbazoles
US6653290B2 (en)	2000-10-06	2003-11-25	Bristol-Myers Squibb Company	Tumor proliferation inhibitors
US7018999B2 (en)	2001-05-16	2006-03-28	Cephalon, Inc.	Methods for the treatment and prevention of pain
US7241779B2 (en) *	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles

2004
- 2004-12-22 US US11/017,947 patent/US7169802B2/en not_active Expired - Lifetime
- 2004-12-23 CN CN200480041770.5A patent/CN1918162B/zh not_active Expired - Lifetime
- 2004-12-23 CA CA2549627A patent/CA2549627C/en not_active Expired - Lifetime
- 2004-12-23 RS RS20110203A patent/RS51886B/sr unknown
- 2004-12-23 KR KR1020127011232A patent/KR20120066057A/ko not_active Ceased
- 2004-12-23 EA EA200601217A patent/EA012295B1/ru not_active IP Right Cessation
- 2004-12-23 SG SG200809413-8A patent/SG149045A1/en unknown
- 2004-12-23 DK DK04815262.3T patent/DK1704148T3/da active
- 2004-12-23 TW TW093140222A patent/TWI355385B/zh not_active IP Right Cessation
- 2004-12-23 JP JP2006547322A patent/JP5006046B2/ja not_active Expired - Lifetime
- 2004-12-23 NZ NZ548099A patent/NZ548099A/en not_active IP Right Cessation
- 2004-12-23 AU AU2004309394A patent/AU2004309394B2/en not_active Expired
- 2004-12-23 PL PL04815262T patent/PL1704148T3/pl unknown
- 2004-12-23 PT PT04815262T patent/PT1704148E/pt unknown
- 2004-12-23 SI SI200431670T patent/SI1704148T1/sl unknown
- 2004-12-23 EP EP04815262A patent/EP1704148B1/en not_active Expired - Lifetime
- 2004-12-23 MY MYPI20045332A patent/MY143373A/en unknown
- 2004-12-23 HR HR20110373T patent/HRP20110373T1/hr unknown
- 2004-12-23 MY MYPI20093362A patent/MY158159A/en unknown
- 2004-12-23 BR BRPI0418113A patent/BRPI0418113B8/pt active IP Right Grant
- 2004-12-23 DE DE602004031672T patent/DE602004031672D1/de not_active Expired - Lifetime
- 2004-12-23 AT AT04815262T patent/ATE500256T1/de active
- 2004-12-23 WO PCT/US2004/043160 patent/WO2005063763A1/en not_active Ceased
- 2004-12-23 KR KR1020067014792A patent/KR101179372B1/ko not_active Expired - Fee Related
- 2004-12-27 AR ARP040104890A patent/AR047168A1/es not_active Application Discontinuation
2006
- 2006-06-18 IL IL176384A patent/IL176384A/en active IP Right Grant
- 2006-06-22 IS IS8519A patent/IS8519A/xx unknown
- 2006-06-29 US US11/477,639 patent/US7671064B2/en active Active
- 2006-07-10 NO NO20063196A patent/NO336893B1/no not_active IP Right Cessation
- 2006-07-17 MA MA29192A patent/MA28298A1/fr unknown
- 2006-07-19 CR CR8519A patent/CR8519A/es unknown
2010
- 2010-02-18 US US12/708,306 patent/US8044064B2/en not_active Expired - Lifetime
2011
- 2011-06-01 CY CY20111100533T patent/CY1111524T1/el unknown
- 2011-09-16 US US13/234,501 patent/US8383813B2/en not_active Expired - Lifetime
2015
- 2015-09-23 NO NO20151245A patent/NO20151245A1/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MY158159A (en)	2016-09-15
US8383813B2 (en)	2013-02-26
US8044064B2 (en)	2011-10-25
SI1704148T1 (sl)	2011-06-30
NO20151245A1 (no)	2015-09-23
EP1704148A1 (en)	2006-09-27
EA012295B1 (ru)	2009-08-28
KR20120066057A (ko)	2012-06-21
SG149045A1 (en)	2009-01-29
NO336893B1 (no)	2015-11-23
DE602004031672D1 (de)	2011-04-14
RS51886B (sr)	2012-02-29
DK1704148T3 (da)	2011-06-14
BRPI0418113B1 (pt)	2020-04-14
US20120004253A1 (en)	2012-01-05
MY143373A (en)	2011-04-29
CR8519A (es)	2007-06-06
BRPI0418113B8 (pt)	2021-05-25
US20060247294A1 (en)	2006-11-02
ATE500256T1 (de)	2011-03-15
CY1111524T1 (el)	2015-08-05
KR101179372B1 (ko)	2012-09-03
US20100152196A1 (en)	2010-06-17
PT1704148E (pt)	2011-05-25
AU2004309394B2 (en)	2011-04-28
JP5006046B2 (ja)	2012-08-22
TWI355385B (en)	2012-01-01
HK1096096A1 (en)	2007-05-25
US20050143442A1 (en)	2005-06-30
CN1918162B (zh)	2014-05-14
MA28298A1 (fr)	2006-11-01
BRPI0418113A (pt)	2007-04-17
IL176384A0 (en)	2006-10-05
TW200530243A (en)	2005-09-16
CN1918162A (zh)	2007-02-21
JP2007516293A (ja)	2007-06-21
CA2549627A1 (en)	2005-07-14
AU2004309394A1 (en)	2005-07-14
AR047168A1 (es)	2006-01-11
EP1704148B1 (en)	2011-03-02
NZ548099A (en)	2010-05-28
IS8519A (is)	2006-06-22
EA200601217A1 (ru)	2006-12-29
US7671064B2 (en)	2010-03-02
NO20063196L (no)	2006-09-20
WO2005063763A1 (en)	2005-07-14
HRP20110373T1 (hr)	2011-06-30
CA2549627C (en)	2012-12-11
IL176384A (en)	2015-05-31
KR20060127069A (ko)	2006-12-11
US7169802B2 (en)	2007-01-30

Publication	Publication Date	Title
ZA200603879B (en)	2010-01-27	Substituted indazole-O-glucosides
IL175490A0 (en)	2011-08-01	Substituted indazole-o-glucosides
EP1680131A4 (en)	2009-05-27	SUBSTITUTED INDOLE-O-GLUCOSIDES
DE502004011703D1 (en)	2010-11-11	N-heterocyclyl-phenylsubstituierte cyclische ketoenole
DE602004012071D1 (en)	2008-04-10	T-hilfe
ZA200603880B (en)	2010-01-27	Substituted indole-O-glucosides
EP1633834A4 (en)	2008-08-20	IMPROVED LUBRICANT QUALITY LUBRICANT
DE502004009243D1 (en)	2009-05-07	Spirocyclische cyclohexan-derivate
DE502004003476D1 (en)	2007-05-24	Standfuss
MY143373A (en)	2011-04-29	Novel fused pyrrolocarbazoles
MY142713A (en)	2010-12-31	Novel fused pyrrolocarbazoles
DE502004006683D1 (en)	2008-05-08	Injection-locked-oscillator-schaltkreis
SG112110A1 (en)	2005-06-29	Glasses
DE502004004146D1 (en)	2007-08-02	Pyrazolverbindungen
DE112004002769D2 (en)	2006-11-09	Schienengeführtes transportsystem
ZA200603778B (en)	2009-07-29	Novel oxy-nitriles
DE502004011343D1 (en)	2010-08-12	Rotorspinnmaschine
ZA200600430B (en)	2009-08-26	Substituted spirobenzazepines
GB0318094D0 (en)	2003-09-03	Novel combination
DE502004012153D1 (en)	2011-03-10	Rotorspinnmaschine
GB0325291D0 (en)	2003-12-03	Novel combination
DE10394343D2 (en)	2006-08-24	Berührungslose biometrische erkennung
IL175678A0 (en)	2006-09-05	Novel piperidine-substituted indoles-or heteroderivatives thereof
DE602004009041D1 (en)	2007-10-31	Hydroxytetrahydronaphthalenylharnstoffderivate
DE602004008281D1 (en)	2007-09-27	Avermectin-b1-monosaccharidderivative